Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study.

Gupta S, Pole JD, Baxter NN, Sutradhar R, Lau C, Nagamuthu C, Nathan PC.

Cancer Med. 2019 Mar 26. doi: 10.1002/cam4.2096. [Epub ahead of print]

2.

Clinical management of Australian adolescents and young adults with acute lymphoblastic and myeloid leukemias: A national population-based study.

White VM, Skaczkowski G, Pinkerton R, Coory M, Osborn M, Bibby H, Nicholls W, Orme LM, Conyers R, Phillips MB, Harrup R, Walker R, Thompson K, Anazodo A.

Pediatr Blood Cancer. 2018 Nov;65(11):e27349. doi: 10.1002/pbc.27349. Epub 2018 Jul 24.

PMID:
30039912
3.

Adoption of pediatric-inspired acute lymphoblastic leukemia regimens by adult oncologists treating adolescents and young adults: A population-based study.

Muffly L, Lichtensztajn D, Shiraz P, Abrahão R, McNeer J, Stock W, Keegan T, Gomez SL.

Cancer. 2017 Jan 1;123(1):122-130. doi: 10.1002/cncr.30322. Epub 2016 Sep 13.

4.

Adolescents with acute lymphoblastic leukemia treated at pediatric versus adult hospitals.

Pole JD, Alibhai SM, Ethier MC, Teuffel O, Portwine C, Zelcer S, Johnston DL, Silva M, Alexander S, Brandwein JM, Sung L.

Ann Oncol. 2013 Mar;24(3):801-6. doi: 10.1093/annonc/mds518. Epub 2012 Oct 28.

PMID:
23108950
5.

[Retrospective Analysis of the Impact of Treatment on Prognosis in 44 Adolescents and Young Adult Patients with Acute Lymphoblastic Leukemia].

Chen XP, Lv N, Li YH, Jing Y, Yu L.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Feb;24(1):14-8. doi: 10.7534/j.issn.1009-2137.2016.01.003. Chinese.

PMID:
26913386
6.

Risk-Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults.

Guzauskas GF, Villa KF, Vanhove GF, Fisher VL, Veenstra DL.

J Adolesc Young Adult Oncol. 2017 Mar;6(1):53-61. doi: 10.1089/jayao.2016.0049. Epub 2016 Oct 25.

7.

Survival differences between adolescents/young adults and children with B precursor acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation.

Burke MJ, Gossai N, Wagner JE, Smith AR, Bachanova V, Cao Q, MacMillan ML, Stefanski HS, Weisdorf DJ, Verneris MR.

Biol Blood Marrow Transplant. 2013 Jan;19(1):138-42. doi: 10.1016/j.bbmt.2012.08.020. Epub 2012 Sep 6.

8.

Patterns of care and outcomes in adolescent and young adult acute lymphoblastic leukemia: a population-based study.

Muffly L, Alvarez E, Lichtensztajn D, Abrahão R, Gomez SL, Keegan T.

Blood Adv. 2018 Apr 24;2(8):895-903. doi: 10.1182/bloodadvances.2017014944.

9.

Augmented Berlin-Frankfurt-Münster therapy in adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL).

Rytting ME, Thomas DA, O'Brien SM, Ravandi-Kashani F, Jabbour EJ, Franklin AR, Kadia TM, Pemmaraju N, Daver NG, Ferrajoli A, Garcia-Manero G, Konopleva MY, Cortes JE, Borthakur G, Garris R, Cardenas-Turanzas M, Schroeder K, Jorgensen JL, Kornblau SM, Kantarjian HM.

Cancer. 2014 Dec 1;120(23):3660-8. doi: 10.1002/cncr.28930. Epub 2014 Jul 17.

10.

Adolescents and Young Adults with Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia: Impact of Care at Specialized Cancer Centers on Survival Outcome.

Wolfson J, Sun CL, Wyatt L, Stock W, Bhatia S.

Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):312-320. doi: 10.1158/1055-9965.EPI-16-0722. Epub 2017 Feb 16.

11.

Adolescents and young adults with acute lymphoblastic leukemia have a better outcome when treated with pediatric-inspired regimens: systematic review and meta-analysis.

Ram R, Wolach O, Vidal L, Gafter-Gvili A, Shpilberg O, Raanani P.

Am J Hematol. 2012 May;87(5):472-8. doi: 10.1002/ajh.23149. Epub 2012 Mar 3. Review.

12.

Acute lymphoblastic leukemia in adolescents and young adults in Finland.

Usvasalo A, Räty R, Knuutila S, Vettenranta K, Harila-Saari A, Jantunen E, Kauppila M, Koistinen P, Parto K, Riikonen P, Salmi TT, Silvennoinen R, Elonen E, Saarinen-Pihkala UM.

Haematologica. 2008 Aug;93(8):1161-8. doi: 10.3324/haematol.12466. Epub 2008 Jun 12.

13.

Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Adolescents and Young Adults.

Hangai M, Urayama KY, Tanaka J, Kato K, Nishiwaki S, Koh K, Noguchi M, Kato K, Yoshida N, Sato M, Goto H, Yuza Y, Hashii Y, Atsuta Y, Mizuta S, Kato M.

Biol Blood Marrow Transplant. 2019 Apr 17. pii: S1083-8791(19)30237-X. doi: 10.1016/j.bbmt.2019.04.014. [Epub ahead of print]

PMID:
31002992
14.

The Initiative to Maximize Progress in Adolescent and Young Adult Cancer Therapy (IMPACT) Cohort Study: a population-based cohort of young Canadians with cancer.

Baxter NN, Daly C, Gupta S, Pole JD, Sutradhar R, Greenberg ML, Nathan PC.

BMC Cancer. 2014 Nov 3;14:805. doi: 10.1186/1471-2407-14-805.

15.

Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.

Ribera JM, Oriol A, Sanz MA, Tormo M, Fernández-Abellán P, del Potro E, Abella E, Bueno J, Parody R, Bastida P, Grande C, Heras I, Bethencourt C, Feliu E, Ortega JJ.

J Clin Oncol. 2008 Apr 10;26(11):1843-9. doi: 10.1200/JCO.2007.13.7265.

PMID:
18398150
16.

Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma.

Kahn JM, Keegan TH, Tao L, Abrahão R, Bleyer A, Viny AD.

Cancer. 2016 Sep 1;122(17):2723-30. doi: 10.1002/cncr.30089. Epub 2016 Jun 10.

17.

Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group.

Hayakawa F, Sakura T, Yujiri T, Kondo E, Fujimaki K, Sasaki O, Miyatake J, Handa H, Ueda Y, Aoyama Y, Takada S, Tanaka Y, Usui N, Miyawaki S, Suenobu S, Horibe K, Kiyoi H, Ohnishi K, Miyazaki Y, Ohtake S, Kobayashi Y, Matsuo K, Naoe T; Japan Adult Leukemia Study Group (JALSG).

Blood Cancer J. 2014 Oct 17;4:e252. doi: 10.1038/bcj.2014.72.

18.

Management of Sarcoma in Adolescents and Young Adults: An Australian Population-Based Study.

White VM, Orme LM, Skaczkowski G, Pinkerton R, Coory M, Osborn M, Bibby H, Nicholls W, Conyers R, Phillips MB, Harrup R, Walker R, Thompson K, Anazodo A.

J Adolesc Young Adult Oncol. 2019 Mar 1. doi: 10.1089/jayao.2018.0136. [Epub ahead of print]

PMID:
30822262
19.

[Acute lymphoblastic leukemia in adolescents and young adults].

Hayakawa F.

Rinsho Ketsueki. 2015 Oct;56(10):2032-8. doi: 10.11406/rinketsu.56.2032. Review. Japanese.

PMID:
26458442
20.

Influence of insurance and marital status on outcomes of adolescents and young adults with acute lymphoblastic leukemia.

Fintel AE, Jamy O, Martin MG.

Clin Lymphoma Myeloma Leuk. 2015 Jun;15(6):364-7. doi: 10.1016/j.clml.2014.12.006. Epub 2014 Dec 12.

PMID:
25592548

Supplemental Content

Support Center